Reversing gastric bypass may not reverse hormonal changes caused by surgery

May 15, 2014 by Angela Koenig

(Medical Xpress)—Gastric bypass surgery has been shown to be one of the most effective treatments for obesity, and often improves Type 2 diabetes immediately after surgery and long before any weight loss has occurred—a phenomenon that's been attributed to earlier and larger insulin response to meal ingestion.

How and why these changes occur after , however, is the ongoing pursuit of University of Cincinnati (UC) researchers.

A recent case study led by Marzieh Salehi, MD, associate professor in the division of endocrinology, metabolism and diabetes, provided Salehi and colleagues the rare opportunity to compare in an eight-year post-surgery gastric bypass patient—with an existing gastric feeding tube due to other medical reasons—to a group of healthy controls.

The study appears in the May online edition of the journal Diabetologia.

What makes this case study so significant, says Salehi, is that the participant could ingest nutrients both orally and via the gastric feeding tube (going through or bypassing foregut, a re-routed stomach pouch attached to the small intestine), allowing researchers to test whether the actual route of meal ingestion made a difference when it came to how the participant's body metabolized glucose.

While it is commonly agreed that weight loss-independent effects of gastric bypass on glucose metabolism are due to the enhanced secretion, and action, of one of the gut hormones, GLP-1, the question remained as to whether this increase is due to the rapid transit of nutrients through the reconfigured gastrointestinal tract.

The study's key finding, says Salehi, is that the gastric bypass patient she studied had increased plasma GLP-1 concentrations and GLP-1 action independent of the route of feeding compared to healthy controls, making it "likely that the increased secretion and action of GLP-1 after gastric bypass surgery is not entirely due to rapid passage of nutrients into the lower gut."

Although these findings pertain to a single-person , Salehi says they are in keeping with previous results that indicated an increased role of GLP-1 in the insulin response following gastric bypass.

"Understanding the underlying mechanisms by which gastric bypass improves blood sugar levels will guide the development of therapeutic options, as GLP-1 based drugs have been utilized for treatment of diabetes over the last decade," says Salehi.

These findings are of particular interest to Salehi, who studies a subset of gastric bypass patients who, post-surgery, develop post-meal hypoglycemia (low blood sugar resulting from too much insulin secretion).

"In patients with severe hypoglycemia, gastric bypass reversal is a consideration," Salehi says, "but our new findings show that simply reversing several years after surgery may not reverse the hormonal effects brought on by the surgery itself, namely a new 'cross-talk' between gut and pancreas."

Explore further: Cause for exaggerated insulin response in subset of bariatric surgery patients identified

Related Stories

Cause for exaggerated insulin response in subset of bariatric surgery patients identified

March 27, 2014
University of Cincinnati (UC) researchers have discovered that altered islet cell function and reduced insulin clearance contribute to excessive post-meal insulin response in patients experiencing low blood sugar symptoms ...

Hormone action likely culprit of hypoglycemia after gastric bypass surgery

March 12, 2014
(Medical Xpress)—Researchers at the University of Cincinnati (UC) have discovered that blocking the action of one of the gut hormones can correct post-meal hypoglycemia (low blood sugar) in gastric bypass patients.

Research reveals hormone action that could lead to treatments for type 2 diabetes

September 30, 2011
(Medical Xpress) -- Researchers at the University of Cincinnati have discovered that the immediate improvement in blood sugar (blood glucose) for those with type 2 diabetes who undergo gastric bypass surgery is related to ...

Gut hormone test predicts individual efficacy of gastric bypass

November 8, 2013
The sensitivity of the GLP-1 hormone, which is secreted by the gastrointestinal tract, can predict the metabolic efficacy of a gastric bypass. The use of a GLP1 challenge could thus function as a novel predictive biomarker ...

Adjustable gastric banding more effective when combined with gastrointestinal hormone GLP-1

June 20, 2013
Pharmacological activation of the receptor for glucagon-like peptide 1 (GLP-1) in conjunction with adjustable gastric banding (AGB) surgery may improve weight loss outcomes achieved with this procedure when compared to performing ...

Recommended for you

Diabetes pill might replace injection to control blood sugar

October 17, 2017
(HealthDay)— An injectable class of diabetes medication—called glucagon-like peptide-1 or GLP-1—might one day be available in pill form, research suggests.

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.